TRIB Market Analysis
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—Forward 4.54
EPS (TTM)$-60.00-77.3% YoY
Profit margin-85.4%HEALTHCARE
Market cap$6.0MMicro cap
Valuation
- Forward P/E
- 4.54
- PEG ratio
- 0.30
- P/B
- 5.75
- P/S (TTM)
- 0.14
- EV/EBITDA
- -6.06
Profitability & growth
- ROE (TTM)
- -1913.0%
- Operating margin
- -10.0%
- Revenue growth YoY
- -5.5%
- Dividend yield
- —
- Beta
- 0.97
Last earnings
Apr 30, 2026 · Reported $-28.12
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Trinity Biotech plc
Company profileTrinity Biotech plc acquires, develops, manufactures and markets medical diagnostic products for the clinical laboratory and point of care (POC) segments of the diagnostic market in the United States, Africa, Asia and Europe. The company is headquartered in Bray, Ireland.
Classification
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- IDA BUSINESS PARK, BRAY, IRELAND
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$6.0M
Shares outstanding$813130
52W high$52.50
52W low$6.85
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent